{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:08:29Z","timestamp":1780510109846,"version":"3.54.1"},"reference-count":23,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34-DA035331"],"award-info":[{"award-number":["R34-DA035331"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["T32-AI102623"],"award-info":[{"award-number":["T32-AI102623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23-AA023869"],"award-info":[{"award-number":["K23-AA023869"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing naloxone awareness and carrying among individuals who misuse opioid analgesic medications (OAs) could reduce opioid overdose mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Self-report surveys were completed by 322 adults receiving residential addiction treatment who misused OAs in the past year. Descriptive analyses and prevalence ratios (using Poisson generalized estimating equations) examined whether illegal opioid (e.g., heroin) initiation was associated with naloxone awareness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among this sample of participants who misused OAs, naloxone awareness was lowest among those who never used illegal opioids (26%) and highest among those who transitioned from OAs to illegal opioid use over time (83%). Naloxone awareness remained higher among participants who had used illegal opioids after adjustment for sociodemographic and substance use characteristics. Those who used OAs before initiating illegal opioids were 2.3-fold (95% CI: 1.5\u20133.3) more likely to have naloxone awareness than those who had only misused OAs after adjustment. Half of participants who had only used OAs had experienced an overdose, 75% had witnessed an overdose, and 61% were prescribed OAs to treat pain in the past 6\u2009months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Implementing overdose education and naloxone distribution programs during addiction treatment could bolster naloxone awareness among people who misuse OAs but who have not used illegal opioids.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2020.1784361","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T15:32:42Z","timestamp":1595345562000},"page":"372-376","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Opportunities to Boost Naloxone Awareness among People who Misuse Opioid Analgesics who have not used Illegal Opioids"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6385","authenticated-orcid":false,"given":"Rachel E.","family":"Gicquelais","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.B.","family":"Bohnert","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA"},{"name":"Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA"},{"name":"Department of Anesthesiology, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.06.005"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.07.003"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2018.06.005"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000235"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00034"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.370"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-2-201001190-00006"},{"key":"e_1_3_6_10_1","article-title":"Associations of nonmedical pain reliever use and initiation of heroin use in the United States","author":"Muhuri P","year":"2013","unstructured":"Muhuri P, , Gfroerer J, , Davies M. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review. 2013. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DR006\/DR006\/nonmedical-pain-reliever-use-2013.htm.","journal-title":"CBHSQ Data Review"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000451"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0317-3"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.01.014"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.02.003"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2017.1394508"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwh090"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.11.008"},{"key":"e_1_3_6_18_1","volume-title":"Treatment Episode Data Set (TEDS): 2017. Admissions to and Discharges from Publicly-Funded Substance Use Treatment","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality.","year":"2019","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2017. Admissions to and Discharges from Publicly-Funded Substance Use Treatment. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2019. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/cbhsq-reports\/TEDS-2017.pdf."},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.07.004"},{"key":"e_1_3_6_20_1","volume-title":"Opioid Overdose Prevention and Related Trauma: Incorporating Overdose Prevention, Response, and Experience into Substance Use Disorder Treatment","author":"Doe-Simkins M","year":"2014","unstructured":"Doe-Simkins M, , Bell A. Opioid Overdose Prevention and Related Trauma: Incorporating Overdose Prevention, Response, and Experience into Substance Use Disorder Treatment. Chicago, IL: Illinois Cooccurring Center for Excellence at Heartland Health Outreach; 2014. https:\/\/prescribetoprevent.org\/wp2015\/wp-content\/uploads\/Incorporating-OD-into-SUD-Tx-12.141.pdf."},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224686"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-7-3"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3895-8"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.10.005"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1784361","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2020.1784361","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2020.1784361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T17:27:39Z","timestamp":1780507659000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2020.1784361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1080\/08897077.2020.1784361"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2020.1784361","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}